Hyaluronidase

This classification denotes an adjuvant with the molecular formula C2327H3553N589O667S20, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8KOG53Z5EM, more generally known as hyaluronidase. European Medicines Agency schedules hyaluronidase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02552MIG. The term HYALURONIDASE is an International Non-Proprietary Name or INN. HYALURONIDASE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule hyaluronidase under HS 35079090 and SITC 51691. As of Q4 2014, HYALURONIDASE remains the US FDA Preferred Term for this commodity. Hyaluronidase bears US NLM identifiers UMLS ID C0020197 and NCI Concept Code C87576. SMILES: NONE.